IP Library Granted Patent US 7,799,004
Granted Patent B2
US 7,799,004 · App. 10/090,358 · Granted Sep 21, 2010

Negative pressure wound treatment apparatus and infection identification system and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,799,004
App. No.
10/090,358
Granted
Sep 21, 2010
Kind
B2
Abstract

A vacuum assisted wound closure device having a means for identifying infectious agents within a wound site. The vacuum assisted wound closure device includes a screen for placement within a wound site, a sealing means for covering the wound site, and a vacuum source in fluid communication with the screen. A canister may be disposed between the screen and vacuum source, such that fluids or other exudates that may be drawn from the wound during application of negative pressure by the vacuum source are collected in the canister for later disposal. A sensing device, which may be a gas chromatograph, sensor array, or other similar device capable of optically sensing the presence of a bacterial agent or other form of infection being drawn from the wound site, is disposed within the screen or interposed between the screen and the vacuum source.

Claims (92)

1. A negative pressure therapy device, comprising:

a foam pad for placement within a wound bed;

a drape adhered over said screen means and wound bed;

a vacuum source fluidically communicating with said foam pad;

a gas chromatograph, operable to sense compositional characteristics of unfiltered wound fluid from the wound bed, the gas chromatograph interposed between said foam pad and said vacuum source, wherein said gas chromatograph further comprises a photo diode to detect changes in light frequency as unfiltered wound fluid from the wound bed passes the photo diode;

a computer-processing unit comprising a database that stores light frequencies associated with microorganisms;

a software program operable to compare the light frequency detected by the gas chromatograph with the light frequencies stored in the database; and

a collection canister interposed between said foam pad and said gas chromatograph.

2. A negative pressure therapy device, comprising:

a foam pad for placement within a wound bed;

a drape adhered over said foam pad and wound bed;

a vacuum source fluidically communicating with said foam pad;

a flexible conduit for communicating between said foam pad and said vacuum source;

a collection canister interposed between said foam pad and said vacuum source;

a sensor array, operable to sense compositional characteristics of unfiltered wound fluid from the wound bed, interposed between said foam pad and said vacuum source, wherein said compositional characteristics are indicative of infection within the wound and include a presence of at least one of a bacterium or an antigen, wherein the sensor array comprises regions of nonconducting organic material, and wherein the sensor array further comprises regions of conducting organic material compositionally different than the nonconducting organic material; and

wherein said sensor array is embedded within said foam pad.

3. The negative pressure therapy device of claim 2 further comprising a flexible conduit for communicating between said foam pad and said vacuum source.

4. The negative pressure therapy device of claim 1 , wherein the microorganisms include at least one of a bacterium or an antigen.

5. The negative pressure therapy device of claim 1 , further comprising:

a display operable to transmit at least one of an audible or visual notification if the software program identifies a match, between the light frequency detected by the gas chromatograph and at least one of the light frequencies stored in the database.

6. The negative pressure therapy device of claim 1 , further comprising:

a filtration mechanism, the gas chromatograph interposed between the wound bed and the filtration mechanism.

7. The negative pressure therapy device of claim 1 , wherein said gas chromatograph is embedded within said foam pad.

8. The negative pressure therapy device of claim 1 , wherein said gas chromatograph is disposed on said drape, such that said gas chromatograph is in contact with said foam pad.

9. The negative pressure therapy device of claim 1 , wherein said gas chromatograph is disposed within said collection canister.

10. A negative pressure therapy device, comprising:

a foam pad for placement within a wound bed;

a drape adhered over said foam pad and wound bed;

a vacuum source fluidically communicating with said foam pad;

a collection canister interposed between said foam pad and said vacuum source;

a flexible conduit for communicating between said foam pad and said vacuum source;

a gas chromatograph, operable to sense compositional characteristics of unfiltered wound fluid from the wound bed, the gas chromatograph interposed between said foam pad and said vacuum source, wherein said gas chromatograph further comprises a photo diode to detect changes in light frequency as unfiltered wound fluid from the wound bed passes the photo diode;

a filtration mechanism, the gas chromatograph interposed between the wound bed and the filtration mechanism;

a computer-processing unit comprising a database that stores light frequencies associated with microorganisms, wherein the microorganisms include at least one of a bacterium or an antigen;

a software program operable to compare the light frequency detected by the gas chromatograph with the light frequencies stored in the database; and

a display transmitting at least one of an audible or visual notification if the software program identifies a match between the light frequency detected by the gas chromatograph and at least one of the light frequencies stored in the database.

11. The negative pressure therapy device of claim 10 , wherein said gas chromatograph is embedded within said foam pad.

12. The negative pressure therapy device of claim 10 , wherein said gas chromatograph is disposed on said drape, such that said gas chromatograph is in contact with said foam pad.

13. The negative pressure therapy device of claim 10 , wherein said gas chromatograph is disposed within said collection canister.

14. A negative pressure therapy device, comprising:

a foam pad for placement within a wound bed;

a drape adhered over said foam pad and wound bed;

a vacuum source fluidically communicating with said foam pad;

a flexible conduit for communicating between said foam pad and said vacuum source;

a collection canister interposed between said foam pad and said vacuum source;

a sensor array, operable to sense compositional characteristics of unfiltered wound fluid from the wound bed, interposed between said foam pad and said vacuum source, wherein said compositional characteristics are indicative of infection within the wound and include a presence of at least one of a bacterium or an antigen, wherein the sensor array comprises regions of nonconducting organic material, and wherein the sensor array further comprises regions of conducting organic material compositionally different than the nonconducting organic material; and

wherein said sensor array is disposed on said drape, such that said sensor array is in contact with said foam pad.

15. The negative pressure therapy device of claim 14 further comprising a flexible conduit for communicating between said foam pad and said vacuum source.

16. A negative pressure therapy device, comprising:

a foam pad for placement within a wound bed;

a drape adhered over said foam pad and wound bed;

a vacuum source fluidically communicating with said foam pad;

a flexible conduit for communicating between said foam pad and said vacuum source;

a collection canister interposed between said foam pad and said vacuum source;

a sensor array, operable to sense compositional characteristics of unfiltered wound fluid from the wound bed, interposed between said foam pad and said vacuum source, wherein said compositional characteristics are indicative of infection within the wound and include a presence of at least one of a bacterium or an antigen, wherein the sensor array comprises regions of nonconducting organic material, and wherein the sensor array further comprises regions of conducting organic material compositionally different than the nonconducting organic material; and

wherein said sensor array is disposed within said collection canister.

17. The negative pressure therapy device of claim 16 further comprising a flexible conduit for communicating between said foam pad and said vacuum source.

18. A negative pressure therapy device, comprising:

a foam pad for placement within a wound bed;

a drape adhered over said screen means and wound bed;

a vacuum source fluidically communicating with said foam pad;

a gas chromatograph, operable to sense compositional characteristics of unfiltered wound fluid from the wound bed, the gas chromatograph interposed between said foam pad and said vacuum source, wherein said gas chromatograph further comprises a photo diode to detect changes in light frequency as unfiltered wound fluid from the wound bed passes the photo diode;

a computer-processing unit comprising a database that stores light frequencies associated with microorganisms;

a software program operable to compare the light frequency detected by the gas chromatograph with the light frequencies stored in the database; and

a filtration mechanism, the gas chromatograph interposed between the wound bed and the filtration mechanism.

19. The negative pressure therapy device of claim 18 , wherein the microorganisms include at least one of a bacterium, or an antigen.

20. The negative pressure therapy device of claim 18 , further comprising:

a display operable to transmit at least one of an audible or visual notification if the software program identifies a match between the light frequency detected by the gas chromatograph and at least one of the light frequencies stored in the database.

21. The negative pressure therapy device of claim 18 , wherein said gas chromatograph is embedded within said foam pad.

22. The negative pressure therapy device of claim 18 , wherein said gas chromatograph is disposed on said drape, such that said gas chromatograph is in contact with said foam pad.

23. A negative pressure therapy device, comprising:

a foam pad for placement within a wound bed;

a drape adhered over said screen means and wound bed;

a vacuum source fluidically communicating with said foam pad;

a gas chromatograph, operable to sense compositional characteristics of unfiltered wound fluid from the wound bed, the gas chromatograph interposed between said foam pad and said vacuum source, wherein said gas chromatograph further comprises a photo diode to detect changes in light frequency as unfiltered wound fluid from the wound bed passes the photo diode;

a computer-processing unit comprising a database that stores light frequencies associated with microorganisms;

a software program operable to compare the light frequency detected by the gas chromatograph with the light frequencies stored in the database; and

wherein said gas chromatograph is embedded with said foam pad.

24. The negative pressure therapy device of claim 23 , wherein the microorganisms include at least one of a bacterium or an antigen.

25. The negative pressure therapy device of claim 23 , further comprising:

a display operable to transmit at least one of an audible or visual notification if the software program identifies a match between the light frequency detected by the gas chromatograph and at least one of the light frequencies stored in the database.

26. A negative pressure therapy device, comprising:

a foam pad for placement within a wound bed;

a drape adhered over said screen means and wound bed;

a vacuum source fluidically communicating with said foam pad;

a gas chromatograph, operable to sense compositional characteristics of unfiltered wound fluid from the wound bed, the gas chromatograph interposed between said foam pad and said vacuum source, wherein said gas chromatograph further comprises a photo diode to detect changes in light frequency as unfiltered wound fluid from the wound bed passes the photo diode;

a computer-processing unit comprising a database that stores light frequencies associated with microorganisms;

a software program operable to compare the light frequency detected by the gas chromatograph with the light frequencies stored in the database; and

wherein said gas chromatograph is disposed on said drape, such that said gas chromatograph is in contact with said foam pad.

27. The negative pressure therapy device of claim 26 , wherein the microorganisms include at least one of a bacterium or an antigen.

28. The negative pressure therapy device of claim 26 , further comprising:

a display operable to transmit at least one of an audible or visual notification if the software program identifies a match between the light frequency detected by the gas chromatograph and at least one of the light frequencies stored in the database.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →